Tumor Treating Fields

Results: 11



#Item
1NOPT-1451 GBM Resource Guide Ad.indd

NOPT-1451 GBM Resource Guide Ad.indd

Add to Reading List

Source URL: www.onclive.com

Language: English - Date: 2015-05-07 09:19:41
2NOPT-1451 GBM Resource Guide Ad.indd

NOPT-1451 GBM Resource Guide Ad.indd

Add to Reading List

Source URL: curemagazine.s3.amazonaws.com

Language: English - Date: 2015-05-07 16:12:34
3Award ID: DP150031 Project Title: A Multi-Targeted Approach for Recurrent Glioblastoma and Other Aggressive Cancers: Exploiting the Potential of IL-4 Fusion Proteins Treatment of Cancer

Award ID: DP150031 Project Title: A Multi-Targeted Approach for Recurrent Glioblastoma and Other Aggressive Cancers: Exploiting the Potential of IL-4 Fusion Proteins Treatment of Cancer

Add to Reading List

Source URL: www.cprit.state.tx.us

Language: English - Date: 2015-03-24 12:30:06
4Novocure Announces the EF-14 Phase III Clinical Trial of Tumor Treating Fields in Patients with Newly Diagnosed Glioblastoma has been Terminated at the Interim Analysis due to Early Success Data presented today as a late

Novocure Announces the EF-14 Phase III Clinical Trial of Tumor Treating Fields in Patients with Newly Diagnosed Glioblastoma has been Terminated at the Interim Analysis due to Early Success Data presented today as a late

Add to Reading List

Source URL: novocure.com

Language: English - Date: 2014-11-20 09:23:21
5Horizon Scanning Briefing Template

Horizon Scanning Briefing Template

Add to Reading List

Source URL: www.horizonscanning.gov.au

Language: English - Date: 2011-03-28 22:54:07
6Novocure™ Certifies Eight Additional Clinical Centers of Excellence to Treat Most Common Brain Tumor with Tumor Treating Fields (TTFields) Therapy By June 1, a total of 15 clinical centers in the U.S. will be certified

Novocure™ Certifies Eight Additional Clinical Centers of Excellence to Treat Most Common Brain Tumor with Tumor Treating Fields (TTFields) Therapy By June 1, a total of 15 clinical centers in the U.S. will be certified

Add to Reading List

Source URL: www.novocure.com

Language: English - Date: 2014-07-10 11:18:41
7Med Oncol[removed]:338 DOI[removed]s12032[removed]SHORT COMMUNICATION  Delayed response and survival from NovoTTF-100A in recurrent

Med Oncol[removed]:338 DOI[removed]s12032[removed]SHORT COMMUNICATION Delayed response and survival from NovoTTF-100A in recurrent

Add to Reading List

Source URL: virtualtrials.com

Language: English - Date: 2013-01-14 14:17:41
8Novocure™ Establishes Initial Clinical Centers of Excellence for Treatment of Recurrent Glioblastoma Multiforme with Tumor Treating Fields (TTFields)™ Therapy Four clinical sites in the U.S. have completed required t

Novocure™ Establishes Initial Clinical Centers of Excellence for Treatment of Recurrent Glioblastoma Multiforme with Tumor Treating Fields (TTFields)™ Therapy Four clinical sites in the U.S. have completed required t

Add to Reading List

Source URL: virtualtrials.com

Language: English - Date: 2011-12-03 17:34:25
9Novocure™ Establishes Initial Clinical Centers of Excellence for Treatment of Recurrent Glioblastoma Multiforme with Tumor Treating Fields (TTFields)™ Therapy Four clinical sites in the U.S. have completed required t

Novocure™ Establishes Initial Clinical Centers of Excellence for Treatment of Recurrent Glioblastoma Multiforme with Tumor Treating Fields (TTFields)™ Therapy Four clinical sites in the U.S. have completed required t

Add to Reading List

Source URL: www.virtualtrials.com

Language: English - Date: 2011-12-03 17:34:25
10Med Oncol[removed]:338 DOI[removed]s12032[removed]SHORT COMMUNICATION  Delayed response and survival from NovoTTF-100A in recurrent

Med Oncol[removed]:338 DOI[removed]s12032[removed]SHORT COMMUNICATION Delayed response and survival from NovoTTF-100A in recurrent

Add to Reading List

Source URL: www.virtualtrials.com

Language: English - Date: 2013-01-14 14:17:41